8-K: Burzynski Research Institute CFO Resigns, CEO Takes Over

Burzynski Research Institute, Inc. announced the resignation of its CFO and Secretary, Patryk P. Goscianski, effective April 17, 2026, with Dr. Stanislaw R. Burzynski assuming these roles without additional compensation.

Summary

• Patryk P. Goscianski resigned as Chief Financial Officer (CFO) and Secretary of Burzynski Research Institute, Inc. effective April 17, 2026.
• The resignation was not due to any disagreements regarding the company's operations, policies, or practices.
• Dr. Stanislaw R. Burzynski, currently President, Chairman of the Board, and principal executive officer, has been appointed as the new CFO and Secretary.
• Dr. Burzynski will now serve as both the principal executive officer and principal financial officer.
• No additional compensation will be provided to Dr. Burzynski for these new roles.
• Dr. Burzynski is the controlling stockholder and has existing agreements with the company, including a New License Agreement, Amended and Restated Research Funding Agreement, and Royalty Agreement.
• Dr. Burzynski is the father of board member Gregory S. Burzynski and step-father of board member Monika Szopa-Paszkowiak.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on an executive change without new financial data or strategic shifts. The consolidation of roles could be seen as either efficient or a governance concern, balancing out the sentiment.

Positives

• The transition of CFO duties to Dr. Stanislaw R. Burzynski is effective immediately and without additional compensation, potentially streamlining executive functions.
• The resignation of the previous CFO was amicable and not due to any operational disagreements.
• Dr. Burzynski's dual role as CEO and CFO consolidates leadership and financial oversight under a single executive.
• The company has existing agreements in place with Dr. Burzynski, indicating a long-standing relationship and established operational framework.

Negatives

• The company has lost its CFO and Secretary, requiring a significant leadership change.
• Dr. Stanislaw R. Burzynski, at 83 years old, is now serving in multiple critical executive roles, which could raise concerns about workload and succession planning.
• The concentration of executive power in Dr. Burzynski, who is also the controlling stockholder and has related-party transactions, could be viewed as a governance concern by some stakeholders.

Risks

• Potential for increased workload and strain on Dr. Stanislaw R. Burzynski, who now holds multiple executive positions.
• Concerns regarding succession planning given the age and multiple roles of Dr. Burzynski.
• Potential for perceived conflicts of interest due to Dr. Burzynski's controlling stockholder status and related-party transactions.
• Dependence on a single individual for both executive leadership and financial oversight.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing regarding future financial performance or strategic initiatives.

Management Comments

• Patryk P. Goscianski: 'I am thankful for the opportunity to serve Burzynski Research Institute, Inc. for over past 14 years, and I offer my best wishes for its continued success.'
• Dr. Stanislaw R. Burzynski will serve as both the Company's principal executive officer and principal financial officer without additional compensation.

Industry Context

StockSavvy.ai notes that executive transitions, particularly for critical roles like CFO, are common in the biotechnology and research sectors. The consolidation of CEO and CFO roles under Dr. Burzynski, a long-standing figure and controlling shareholder, is a significant internal governance event that investors will monitor for its impact on operational efficiency and strategic direction.

Management Changes

Corporate Governance

Related Party Transactions

• Dr. Stanislaw R. Burzynski is a party to the New License Agreement, the Amended and Restated Research Funding Agreement, and the Royalty Agreement with the Company.
• Dr. Burzynski is the father of board member Gregory S. Burzynski and step-father of board member Monika Szopa-Paszkowiak.

Stakeholder Impact

• Shareholders: May have concerns about governance due to the concentration of executive power and related-party transactions, but also potential for streamlined operations.
• Employees: The change in financial leadership may create uncertainty, but the continuity of Dr. Burzynski's leadership could also provide stability.
• Creditors: The financial stability and operational continuity remain key, with the consolidation of roles potentially impacting oversight.

Next Steps

• Monitor the operational and financial performance under the new executive structure.
• Observe any future announcements regarding financial reporting or strategic direction.

Key Dates

Keywords

CFO resignation, Burzynski Research Institute, Executive appointment, Stanislaw R. Burzynski, Corporate governance, Financial officer, Secretary, Form 8-K